Premium
No evidence of transfusion transmission of Adenovirus and Epstein–Barr virus infections in paediatric recipients post–bone marrow transplant
Author(s) -
Patel P.,
Tuke P.,
Tettmar K.,
CloutmanGreen E.,
Hartley J.,
Klein N.,
Veys P.,
Tedder R.S.
Publication year - 2015
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/vox.12256
Subject(s) - medicine , bone marrow , blood transfusion , immunology , bone marrow transplant , virus , transmission (telecommunications) , population , adenovirus infection , bone marrow transplantation , virology , environmental health , electrical engineering , engineering
Adenovirus and Epstein–Barr virus can cause significant morbidity and mortality in paediatric patients post–bone marrow transplant. The source of infection is thought to be either reactivation of latent viruses or primary infection. We have investigated whether transfusion of blood components from viraemic donors could provide a route of primary infection in these patients and sought the prevalence of viraemia in the blood donor population from England. In 32 linked donor/recipient samples and 300 unselected blood donors, we found no evidence to suggest that these infections in paediatric bone marrow transplant recipients had been acquired from transfused blood components.